Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
Prif Awdur: | Peddle, CF |
---|---|
Awduron Eraill: | MacLaren, RE |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2021
|
Pynciau: |
Eitemau Tebyg
-
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
gan: Saba Shahin, et al.
Cyhoeddwyd: (2022-04-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
gan: Aarti Bhardwaj, et al.
Cyhoeddwyd: (2022-01-01) -
Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa
gan: Samantha R. De Silva, DPhil, FRCOphth, et al.
Cyhoeddwyd: (2024-03-01) -
Clinical and genetic features of Koreans with retinitis pigmentosa associated with mutations in rhodopsin
gan: Young Hoon Jung, et al.
Cyhoeddwyd: (2023-08-01) -
Stem cells set their sights on retinitis pigmentosa
gan: Jeannette L Bennicelli, et al.
Cyhoeddwyd: (2013-08-01)